4.8 Article

Targeting collagen for diagnostic imaging and therapeutic delivery

期刊

JOURNAL OF CONTROLLED RELEASE
卷 240, 期 -, 页码 323-331

出版社

ELSEVIER SCIENCE BV
DOI: 10.1016/j.jconrel.2016.01.007

关键词

Drug delivery; Collagen binding molecules; Collagen mimetic peptide; Collagen hybridizing peptide; Theranostics; Collagen remodeling; Denatured collagen; ECM remodeling

资金

  1. NIAMS/NIH [R01-AR060484, R21-AR065124]
  2. DOD [W81XWH-12-1-0555]

向作者/读者索取更多资源

As the most abundant protein in mammals and a major structural component in extracellular matrix, collagen holds a pivotal role in tissue development and maintaining the homeostasis of our body. Persistent disruption to the balance between collagen production and degradation can cause a variety of diseases, some of which can be fatal. Collagen remodeling can lead to either an overproduction of collagen which can cause excessive collagen accumulation in organs, common to fibrosis, or uncontrolled degradation of collagen seen in degenerative diseases such as arthritis. Therefore, the ability to monitor the state of collagen is crucial for determining the presence and progression of numerous diseases. This review discusses the implications of collagen remodeling and its detection methods with specific focus on targeting native collagens as well as denatured collagens. It aims to help researchers understand the pathobiology of collagen-related diseases and create novel collagen targeting therapeutics and imaging modalities for biomedical applications. (C) 2016 Elsevier B.V. All rights reserved.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.8
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据